Wordt geladen...
Renal Failure and Rhabdomyolysis Associated With Sitagliptin and Simvastatin Use
BACKGROUND: Sitagliptin is a new oral glucose lowering medication which acts via the incretin hormone system. The most common side effects are headache and pharyngitis, and few serious adverse events were observed during clinical trials. Dose adjustment is recommended in renal insufficiency, but lon...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2008
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2602841/ https://ncbi.nlm.nih.gov/pubmed/19046202 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1464-5491.2008.02536.x |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|